Investment Stage:
N/A
Estimated Revenue:
$1M to $10M
Investor Type:
N/A
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
New York, United States
Founded Date:
2005
Total Funding:
N/A
Technology:
Immunotherapy